medigraphic.com
ISSN 1527-3172 (Electronic)

2011, Number 4

<< Back Next >>

MEDICC Review 2011; 13 (4)

Acute myocardial infarction incidence, mortality and case fatality in Santa Clara, Cuba, 2007–2008

Morales A, Madrazo Y, Ramírez JI, Castañeda L, Machín W, Álvarez L, Angulo R, Dueñas R, Bermúdez R

Language: English
References: 46
Page: 23-29
PDF size: 70.93 Kb.


ABSTRACT

Introduction: Information on acute myocardial infarction incidence and mortality is essential for determining the efficacy of the health system's cardiovascular disease prevention activities; however, in Cuba, sufficient data related to acute myocardial infarction are lacking, particularly at the local level.
Objective: Describe acute myocardial infarction incidence, mortality and case fatality rates from January 2007 through December 2008 in persons aged 45-74 in the municipality of Santa Clara, Villa Clara Province, Cuba.
Methods: A retrospective descriptive study was conducted. The World Health Organization MONItoring Trends and Determinants in CArdiovascular Disease Project (MONICA) methodology was used, but only in part, since out-of-hospital case fatalities were not investigated, resulting in insufficient data for such cases. Cases of acute myocardial infarction covered under MONICA definition 1 were included (non-fatal definite, fatal definite, fatal possible, and unclassifiable deaths). Hospitalized patients were followed for 28 days. Incidence, mortality and case fatality rates in the population were calculated by age group (45–54, 55–64 and 65–74 years) and sex. Age-standardized incidence and mortality rates were calculated using the direct method, with the world population as a reference.
Results: A total of 482 cases of acute myocardial infarction were registered. The percentage of cases of non-fatal definite, fatal definite, fatal possible and fatal with insufficient data were 32%, 18.3%, 26.3% and 13.9% respectively. The cumulative age-standardized incidence per 100,000 population was 433 (95% CI 365–501) in men and 195 (95% CI 152–237) in women, while mortality per 100,000 population was 242 (95% CI 192–292) in men and 120 (95% CI 87–153) in women. Case fatality was 56.4% in men and 62.6% in women. Most fatal cases (65.6%) occurred out of hospital, a trend that was more marked in men (73.9%) than in women (51%).
Conclusions: Case fatality from acute myocardial infarction in Santa Clara residents was high, especially in women. Two thirds of fatalities occurred out of hospital, a higher proportion of these deaths in men. It is recommended that the AMI registry be completed by investigating out-of-hospital case fatalities with insufficient data; expanding it to include the 35-44 age group; and that the supply of cardiac marker enzyme immunoassay test kits in Santa Clara be stabilized.


REFERENCES

  1. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001 Nov 27;104(22):2746–53.

  2. WHO. Estadísticas Sanitarias Mundiales [Internet]. Geneva: World Health Organization; 2009 [cited 2011 Feb 10]. 149 p. Available from : http://www.who.int/whosis/whostat/2009/es/ index.html. Spanish.

  3. Seuc AH, Domínguez Alonso E, Torres Vidal RM, Varona Pérez P. Algunas precisiones acerca de la mortalidad por enfermedades cardiovasculares en Cuba [Internet]. Rev Cub Salud Pública. 2011 Jan-Mar [cited 2011 Feb 10]; 37(1):19–33. Available from: http://www.bvs.sld.cu/revistas/ spu/vol37_01_11/spu04111.htm. Spanish.

  4. Ministry of Public Health (CU). Anuario Estadístico de Salud 2009. Havana: Ministry of Public Health (CU); 2010 [cited 2011 Feb 10]. Available from: http:// les.sld.cu/dne/ les/2010/04/ anuario-2009e3.pdf

  5. Medrano Albero MJ, Boix Martínez R, Cerrato Crespán E, Ramírez Santa-Pau M. Incidencia y prevalencia de cardiopatía isquémica y enfermedad cerebrovascular en España: Revisión sistemática de la literatura. Rev Esp Salud Pública. 2006;80:5–15. Spanish.

  6. Smith SC Jr, Jackson R, Pearson TA, Fuster V, Yusuf S, Faergeman O, et al. Principles for National and Regional Guidelines on CVD Prevention: a Scienti c Statement From the World Heart and Stroke Forum. Circulation. 2004 Jun 29;109(25):3112–21.

  7. Ríos Massabot NE, Fernández Viera RM, Jorge Pérez ER. Los registros médicos en Cuba. Rev Cub Salud Pública. 2005;31(4):345–52. Spanish.

  8. Batista Moliner R, Landrove Rodríguez O, Bonet Gorbea M, Feal Cañizares P, Ramírez M. Sistema de vigilancia de enfermedades no transmisibles en Cuba. Rev Cub Hig Epidemiol. 2000 May–Aug;38(2):77–92. Spanish.

  9. Cañizares Pérez M, Barroso Utra I, Alfonso León A, García Roche R, Alfonso Sagué K, Chang de la Rosa M, et al. Estimaciones usadas en diseños muestrales complejos: aplicaciones en la encuesta de salud cubana del año 2001. Rev Panam Salud Pública. 2004 Mar 31;15(3):176–84. Spanish.

  10. Debs G, La Noval R, Dueñas Herrera A, González Pagés JC. Prevalencia de factores de riesgo coronario en “10 de Octubre”. Rev Cub Cardiol Cir Cardiovasc. 2001;15(1):14–20. Spanish.

  11. Espinosa AD, Ordúñez PO, Alvarez FC, Vázquez LE, Armas Y, Diez E, et al. La Web de Cienfuegos. El Proyecto Global de Cienfuegos. Diez Años después [Internet]. Cienfuegos (CU): El Navegante; 2010 [cited 2010 Sep 10] [about 3 screens]. Available from: http://www.fac.org.ar/ cvirtual/tlibres/tnn2350/tnn2350c.html. Spanish.

  12. Morejón Giraldoni AF. [Concerning the regional initiatives to promote cardiovascular health in Cienfuegos city]. MediSur. 2008;6(3):108–11. Spanish.

  13. Benet Rodríguez M, Morejón Giraldoni A, Espinosa Brito AD, Landrove Rodríguez O, Peraza Alejo D, Ordúñez García PO. Factores de Riesgo para Enfermedades Crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II. MediSur. 2010;8(2):56–9. Spanish.

  14. Ordúñez P, Cooper R, Espinosa A, Iraola M, Bernal JL, La Rosa Y. Enfermedades cardiovasculares en Cuba: determinantes para una epidemia y desafíos para la prevención y control. Rev Cub Salud Pública. 2005;31(4):270–84. Spanish.

  15. Giraldo G. Three-Pronged Innovation to Improve Care for Acute Myocardial Infarction Patients in Cuba. MEDICC Rev. 2010 Jul;12(3):11–6.

  16. Icaza G, Núñez L, Marrugat J, Mujica V, Escobar MC, Jiménez AL, et al. Estimación de riesgo de enfermedad coronaria mediante la función de Framingham adaptada para la población chilena. Rev Med Chil. 2009 Oct;137(10):1273–82. Spanish.

  17. Caccavo A, Álvarez A, Bello FH, Ferrari AE, Carrique AM, Lasdica EA, et al. Incidencia poblacional del infarto con elevación del ST o bloqueo de rama izquierda a lo largo de 11 años en una comunidad de la provincia de Buenos Aires. Rev Argent Cardiol. 2007 May-Jun;75(3):185–8. Spanish.

  18. Ferrante D, Tajer CD. ¿Cuántos infartos hay en la Argentina? Rev Argent Cardiol. 2007 MayJun;75(3):161–2. Spanish.

  19. Marrugat J, Sala J. Registros de morbimortalidad en cardiología. Rev Esp Cardiol. 1997;50:48–57. Spanish.

  20. Cabadés A. El registro REGICOR y la epidemiología del infarto de miocardio en España: se hace camino al andar. Rev Esp Cardiol. 2007 Apr;60(4):342–5. Spanish.

  21. Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999 May 8;353(9164):1547–57.

  22. Gil M, Martí H, Elosúa R, Grau M, Sala J, Masiá R, et al. Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999. Rev Esp Cardiol. 2007 Apr;60(4):349–56. Spanish.

  23. Marrugat J, Subirana I, Comín E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health. 2007 Jan;61(1):40–7.

  24. Grau M, Guxens M, Subirana I, Fitó M, Covas MI, Jacquemin B, et al. South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe. Eur Heart J. 2007 Dec;28(3):2841–9.

  25. Myocardial Infarction Genetics Consortium; Kathiresan S, Voight BF, Purcell S, Musunuru K, Ardissino D, et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet. 2009 Mar;41(3):334–41.

  26. Grau M, Subirana I, Elosua R, Solanas P, Ramos R, Masia R, et al. Trends in cardiovascular risk factor prevalence (1995–2000–2005) in northeastern Spain. Eur J Cardiovasc Prev Rehabil. 2007 Oct;14(5):653–9.

  27. Morales A, Marrugat J, Coca A. Limitaciones de la valoración clínica de obesidad: Re exiones a propósito de la Declaración de la American Heart Association de 2006. Rev Esp Cardiol. 2007 Sep;60(9):992–3. Spanish.

  28. Marrugat J, Morales A, Luna Y, Madrazo Y, Carmona R, Masia R, et al. Comparison of the cardiovascular risk of workers in Spain and Cuba [Internet]. World Congress of Cardiology 2006. September2–6. Barcelona, Spain. 2006 [cited 2010 Sep 10]; [about 2 screens]. Available from: http://spo.escardio.org/AbstractDetails. aspx?id=47386&eevtid=15

  29. Morales A, Dueñas R, Martínez B, Rodríguez A, Pérez GP, Grau M, et al. Cuba singularity: different environmental and coronary heart disease mortality but similar life expectancy at birth than Spain [Internet]. European Congress of Cardiology 2009. August 29–September 2. Barcelona, Spain. 2009 [cited 2010 Sep 10]; [about 2 screens]. Available from: http://spo.escardio.org/ eslides/view.aspx?eevtid=33&fp=3133

  30. Grau M, Morales Salinas A, Redondo A, Elosua R, Ramos R, Marrugat J, et al. Distribución de los factores de riesgo cardiovascular por categorías de actividad física en hombres y mujeres con y sin obesidad abdominal [Internet]. Rev Esp Cardiol. 2009 [cited 2010 Sep 10];62 Supl 3:1– 226. Available from: http://www.congresosec. org/2009/agenda/docs/22823.pdf. Spanish.

  31. Manual of The MONICA Project [Internet]. Geneva: World Health Organization; 2000 [cited 2010 Sep10]. Available from: http://www.ktl. / publications/monica/manual/index.htm

  32. Waterhouse J, Muir CS, Correa P, Powell J, eds. Cancer incidence in ve continents. Lyon: IARC; 1976. 456 p.

  33. Sans S, Puigdefábregas A, Paluzie G, Monterde D, Balaguer-Vintró I. Increasing trends of acute myocardial infarction in Spain: the MONICA–Catalonia study. Eur Heart J. 2005 Mar;(5)26:505–15.

  34. de Vos P, Van der Stuyft P. The right to health in times of economic crisis: Cuba’s way. Lancet. 2009 Nov 7;374(9701):1575–6.

  35. Bardají A, Bueno H, Fernández-Ortiz A, Heras M. Aplicabilidad de la nueva de nición de infarto de miocardio y opinión de los cardiólogos espa- ñoles. Rev Esp Cardiol. 2003 Jan;56(1):23–8. Spanish.

  36. Fiol M, Cabadés A, Sala J, Marrugat J, Elosua R, Vega G, et al. Variabilidad en el manejo hospitalario del infarto agudo de miocardio en España. Estudio IBERICA (Investigación, Búsqueda Especí ca y Registro de Isquemia Coronaria Aguda). Rev Esp Cardiol. 2001 Apr;54(4):443–52. Spanish.

  37. Herasa M, Marrugat J, Arósc F, Boscha X, Enerod J, Suárez MA, et al. Reducción de la mortalidad por infarto agudo de miocardio en un período de cinco años. Rev Esp Cardiol. 2006 Mar;59(3): 200–8. Spanish.

  38. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction. N Engl J Med. 2010 Jun 10;362(23):2155–65.

  39. French JK, White HD. Clinical implications of the new de nition of myocardial infarction. Heart. 2004 Jan;90(1):99–106.

  40. Assomull RG, Lyne JC, Keenan N, Gulati A, Bunce NH, Davies SW, et al. The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J. 2007 May;28(10):1242–9.

  41. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. Heart Disease and Stroke Statistics—2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 Jan 29;117(4):25–146.

  42. Boix R, Aragonés N, Medrano MJ. Tendencias en la mortalidad por cardiopatía isquémica en 50 provincias españolas. Rev Esp Cardiol. 2003;56(9):850–6. Spanish.

  43. Marrugat J, Sala J, Aboal J. Epidemiología de las enfermedades cardiovasculares en la mujer. Rev Esp Cardiol. 2006 Jan;59(1):264–74. Spanish.

  44. Figueras J. Mayor mortalidad en la angioplastia primaria en la mujer. ¿Sigue el enigma del sexo? Rev Esp Cardiol. 2006;59(11):1097–9. Spanish.

  45. Ministry of Public Health (CU). Indicadores Estadísticos Principales. Cuba 2009 [Internet]. 2009 [cited 2010 Sep 10]. Available from: http:// www.sld.cu/galerias/ppt/sitios/cardiologia/ indicadores_estadisticos_principales.ppt. Spanish. Peer R

  46. García J, Cirera L, Tormo MJ, Martínez C, Contreras J, García J, et al. Utilidad del boletín estadístico de defunción para la identi cación de muertes extrahospitalarias en un registro poblacional de infartos agudos de miocardio. Rev Esp Cardiol. 2001 Sep;54(9):1041–7. Spanish.




2020     |     www.medigraphic.com